Report cover image

India Xerostomia Therapeutics Market - Industry Trends and Forecast to 2030

Publisher Data Bridge Market Research
Published Jun 01, 2023
Length 104 Pages
SKU # DAABD18055275

Description

India Xerostomia Therapeutics Market - Industry Trends and Forecast to 2030


The India xerostomia therapeutics market is expected to reach USD 25.20 million by 2030 from USD 16.97 million in 2022, growing at a CAGR of 5.1% during the forecast period of 2023 to 2030.

Market Segmentation

India Xerostomia Therapeutics Market, By Product Type (Saliva Substitutes, Drugs, Salivary Pen, and Others), Type (True Xerostomia and Pseudo Xerostomia Or Symptomatic Xerostomia), Mode of Purchase (Prescription (Rx) and Over The Counter (OTC)), Population (Geriatric and Adults), End User (Dental Clinics, Hospitals, Specialty Clinics, and Home Care), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Sales) - Industry Trends and Forecast to 2030

Overview of India Xerostomia Therapeutics Market Dynamics

Driver
• Advancements in pharmaceutical research and development
Restraint

• High cost associated with xerostomia treatment

Opportunity

• Rising product collaborations and partnerships

Market Players
Some of the major market players operating in the India xerostomia therapeutics market are:
• Colgate-Palmolive Company
• Sun Pharmaceutical Industries Ltd.
• Haleon Group of Companies
• 3M
• Alish Life Saving Impex Private Limited
• GC India Dental
• ICPA Health Products Ltd
• Saliwell Ltd.

Table of Contents

104 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The India Xerostomia Therapeutics Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Stages Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market End User Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel's Model
4.2 Porter's 5 Forces
4.3 Growth Strategies Adopted By The Key Market Players
5 Epidemiology
6 Pipeline Analysis
7 India Xerostomia Therapeutics Market, Regulations
8 Market Overview
8.1 Drivers
8.1.1 Rising Use Of Chemotherapy And Radiotherapy In The Cancer Treatment
8.1.2 Growing Prevalence Of Xerostomia
8.1.3 Advancements In The Pharmaceutical Research And Development
8.1.4 Increasing Usage Of Prescription Medicines
8.2 Restraints
8.2.1 High Cost Associated With Xerostomia Treatment
8.2.2 Side Effects Associated With Xerostomia Therapies
8.3 Opportunities
8.3.1 Rising Product Collaborations And Partnerships
8.3.2 Rising Research And Development Activities For The Development Of Novel Therapies
8.4 Challenges
8.4.1 Lack Of Awareness Of Xerostomia
8.4.2 Lack Of Treatments Available For Xerostomia
9 India Xerostomia Therapeutics Market, By Product Type
9.1 Overview
9.2 Saliva Substitutes
9.2.1 Mouthwash
9.2.2 Toothpaste
9.2.3 Dentifrices
9.2.4 Artificial Saliva
9.2.4.1 Oral Solution
9.2.4.1.1 Oral Spray
9.2.4.1.2 Oral Rinse
9.2.4.1.3 Others
9.2.4.2 Gel
9.2.4.3 Lozenge
9.2.4.4 Dissolving Tablets
9.2.4.5 Swabs
9.2.4.6 Powder
9.2.4.7 Aquoral
9.2.4.8 Salivasure
9.2.4.9 Oasis
9.2.4.10 Caphosol
9.2.4.11 Xylimelts
9.2.4.12 Others
9.2.5 Oil-based Saliva Substitutes
9.2.6 Salivary Stimulants
9.2.7 Chewing Gums
9.3 Drugs
9.3.1 Cholinomimetic Drugs
9.3.1.1 Pilocarpine
9.3.1.2 Cevimeline
9.3.1.3 Anetholetrithione
9.3.2 Yohimbine
9.3.3 Others
9.3.4 Branded
9.3.5 Sialor
9.3.6 Pilocarpine
9.3.7 Salagen
9.3.8 Exovac
9.3.9 Others
9.3.10 Generic
9.4 Salivary Pen
9.5 Other
10 India Xerostomia Therapeutics Market, By Type
10.1 Overview
10.2 True Xerostomia
10.3 Pseudo Xerostomia Or Symptomatic Xerostomia
11 India Xerostomia Therapeutics Market, By Mode Of Purchase
11.1 Overview
11.2 Prescription (Rx)
11.3 Over The Counter (Otc)
12 India Xerostomia Therapeutics Market, By Population Type
12.1 Overview
12.2 Geriatric
12.3 Adults
13 India Xerostomia Therapeutics Market, By End User
13.1 Overview
13.2 Dental Clinics
13.3 Hospitals
13.4 Specialty Clinics
13.5 Home Care
14 India Xerostomia Therapeutics Market, By Distribution Channel
14.1 Overview
14.2 Retail Pharmacies
14.3 Hospital Pharmacies
14.4 Online Sales
15 India Xerostomia Therapeutics Market: Company Landscape
15.1 Company Share Analysis: India
16 Swot Analysis
17 Company Profile
17.1 Colgate-palmolive Company.
17.1.1 Company Snapshot
17.1.2 Revenue Analysis
17.1.3 Product Portfolio
17.1.4 Recent Developments
17.2 Sun Pharmaceutical Industries Ltd.
17.2.1 Company Snapshot
17.2.2 Revenue Analysis
17.2.3 Product Portfolio
17.2.4 Recent Developments
17.3 Haleon Group Of Companies.
17.3.1 Company Snapshot
17.3.2 Revenue Analysis
17.3.3 Product Portfolio
17.3.4 Recent Developments
17.4 3m
17.4.1 Company Snapshot
17.4.2 Revenue Analysis
17.4.3 Product Portfolio
17.4.4 Recent Developments
17.5 Alish Life Saving Impex Private Limited.
17.5.1 Company Snapshot
17.5.2 Product Portfolio
17.5.3 Recent Development
17.6 Gc Corporation.
17.6.1 Company Snapshot
17.6.2 Product Portfolio
17.6.3 Recent Development
17.7 Icpa Health Products Ltd
17.7.1 Company Snapshot
17.7.2 Product Portfolio
17.7.3 Recent Development
17.8 Saliwell Ltd.
17.8.1 Company Snapshot
17.8.2 Product Portfolio
17.8.3 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables
Table 1 India Xerostomia Therapeutics Market, By Product Type, 2021-2030 (Usd Million)
Table 2 India Xerostomia Therapeutics Market, By Product Type, 2021-2030 (Volume)
Table 3 India Saliva Substitutes In Xerostomia Therapeutics Market, By Product Type, 2021-2030 (Usd Million)
Table 4 India Saliva Substitutes In Xerostomia Therapeutics Market, By Product Type, 2021-2030 (Volume)
Table 5 India Artificial Saliva In Xerostomia Therapeutics Market, By Form, 2021-2030 (Usd Million)
Table 6 India Artificial Saliva In Xerostomia Therapeutics Market, By Form, 2021-2030 (Volume)
Table 7 India Oral Solution In Xerostomia Therapeutics Market, By Form, 2021-2030 (Usd Million)
Table 8 India Oral Solution In Xerostomia Therapeutics Market, By Form, 2021-2030 (Volume)
Table 9 India Artificial Saliva In Xerostomia Therapeutics Market, By Brand, 2021-2030 (Usd Million)
Table 10 India Artificial Saliva In Xerostomia Therapeutics Market, By Brand, 2021-2030 (Volume)
Table 11 India Drugs In Xerostomia Therapeutics Market, By Drug, 2021-2030 (Usd Million)
Table 12 India Drugs In Xerostomia Therapeutics Market, By Drug, 2021-2030 (Volume)
Table 13 India Cholinomimetic Drugs In Xerostomia Therapeutics Market, By Drug, 2021-2030 (Usd Million)
Table 14 India Cholinomimetic Drugs In Xerostomia Therapeutics Market, By Drug, 2021-2030 (Volume)
Table 15 India Drugs In Xerostomia Therapeutics Market, By Drug Type, 2021-2030 (Usd Million)
Table 16 India Branded In Xerostomia Therapeutics Market, By Drug Type, 2021-2030 (Usd Million)
Table 17 India Branded In Xerostomia Therapeutics Market, By Drug Type, 2021-2030 (Volume)
Table 18 India Xerostomia Therapeutics Market, By Type, 2021-2030 (Usd Million)
Table 19 India Xerostomia Therapeutics Market, By Mode Of Purchase, 2021-2030 (Usd Million)
Table 20 India Xerostomia Therapeutics Market, By Population Type, 2021-2030 (Usd Million)
Table 21 India Xerostomia Therapeutics Market, By End User, 2021-2030 (Usd Million)
Table 22 India Xerostomia Therapeutics Market, By Distribution Channel, 2021-2030 (Usd Million)
List Of Figures
Figure 1 The India Xerostomia Therapeutics Market: Segmentation
Figure 2 The India Xerostomia Therapeutics Market: Data Triangulation
Figure 3 The India Xerostomia Therapeutics Market: Droc Analysis
Figure 4 The India Xerostomia Therapeutics Market: Global Vs Regional Market Analysis
Figure 5 The India Xerostomia Therapeutics Market: Company Research Analysis
Figure 6 The India Xerostomia Therapeutics Market: Interview Demographics
Figure 7 The India Xerostomia Therapeutics Market: Dbmr Market Position Grid
Figure 8 The India Xerostomia Therapeutics Market: End User Coverage Grid
Figure 9 The India Xerostomia Therapeutics Market: Vendor Share Analysis
Figure 10 The India Xerostomia Therapeutics Market: Segmentation
Figure 11 The Rising Use Of Chemotherapy And Radiotherapy In The Cancer Treatment Is Expected To Drive The India Xerostomia Therapeutics Market In The Forecast Period
Figure 12 Product Type Segment Is Expected To Account For The Largest Share Of The India Xerostomia Therapeutics Market In 2023 & 2030
Figure 13 Drivers, Restraints, Opportunities And Challenges Of India Xerostomia Therapeutics Market
Figure 14 India Xerostomia Therapeutics Market: By Product Type, 2022
Figure 15 India Xerostomia Therapeutics Market: By Product Type, 2023-2030 (Usd Million)
Figure 16 India Xerostomia Therapeutics Market: By Product Type, Cagr (2023-2030)
Figure 17 India Xerostomia Therapeutics Market: By Product Type, Lifeline Curve
Figure 18 India Xerostomia Therapeutics Market: By Type, 2022
Figure 19 India Xerostomia Therapeutics Market: By Type, 2023-2030 (Usd Million)
Figure 20 India Xerostomia Therapeutics Market: By Type, Cagr (2023-2030)
Figure 21 India Xerostomia Therapeutics Market: By Type, Lifeline Curve
Figure 22 India Xerostomia Therapeutics Market: By Mode Of Purchase ,2022
Figure 23 India Xerostomia Therapeutics Market: By Mode Of Purchase, 2023-2030 (Usd Million)
Figure 24 India Xerostomia Therapeutics Market: By Mode Of Purchase , Cagr (2023-2030)
Figure 25 India Xerostomia Therapeutics Market: By Mode Of Purchase , Lifeline Curve
Figure 26 India Xerostomia Therapeutics Market: By Population Type, 2022
Figure 27 India Xerostomia Therapeutics Market: By Population Type, 2023-2030 (Usd Million)
Figure 28 India Xerostomia Therapeutics Market: By Population Type, Cagr (2023-2030)
Figure 29 India Xerostomia Therapeutics Market: By Population Type, Lifeline Curve
Figure 30 India Xerostomia Therapeutics Market: By End User, 2022
Figure 31 India Xerostomia Therapeutics Market: By End User, 2023-2030 (Usd Million)
Figure 32 India Xerostomia Therapeutics Market: By End User, Cagr (2023-2030)
Figure 33 India Xerostomia Therapeutics Market: By End User, Lifeline Curve
Figure 34 India Xerostomia Therapeutics Market: By Distribution Channel, 2022
Figure 35 India Xerostomia Therapeutics Market: By Distribution Channel, 2023-2030 (Usd Million)
Figure 36 India Xerostomia Therapeutics Market: By Distribution Channel, Cagr (2023-2030)
Figure 37 India Xerostomia Therapeutics Market: By Distribution Channel, Lifeline Curve
Figure 38 India Xerostomia Therapeutics Market: Company Share 2022 (%) 87

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us